tradingkey.logo

BRIEF-Maxcyte Says Enters Strategic Platform License With TG Therapeutics

ReutersFeb 12, 2025 7:18 AM

- MaxCyte Inc MXCT.O:

  • MAXCYTE, INC. MAXCYTE, INC. - MXCR - STRATEGIC PLATFORM LICENSE WITH TG THERAPEUTICS

  • MAXCYTE INC - ENTERS STRATEGIC PLATFORM LICENSE WITH TG THERAPEUTICS

  • MAXCYTE INC - TG THERAPEUTICS OBTAINS RIGHTS TO USE MAXCYTE TECHNOLOGY

Source text: ID:nRSL7610Wa

Further company coverage: MXCT.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI